Dianthus Therapeutics Stock Price on December 31, 2023
| DNTH Stock | 23.60 0.24 1.03% |
Below is the normalized historical share price chart for Dianthus Therapeutics extending back to June 21, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Dianthus Therapeutics stands at 23.60, as last reported on the 19th of November, with the highest price reaching 24.10 and the lowest price hitting 22.88 during the day.
If you're considering investing in Dianthus Stock, it is important to understand the factors that can impact its price. Dianthus Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0663, which denotes the company had a -0.0663% return per unit of standard deviation over the last 3 months. Dianthus Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dianthus Therapeutics' Coefficient Of Variation of (1,474), mean deviation of 2.6, and Standard Deviation of 3.5 to check the risk estimate we provide.
As of now, Dianthus Therapeutics' Total Stockholder Equity is increasing as compared to previous years. The Dianthus Therapeutics' current Stock Based Compensation is estimated to increase to about 3.8 M, while Common Stock Shares Outstanding is projected to decrease to under 2.8 M. . The current Price To Sales Ratio is estimated to decrease to 18.02. The current Price Earnings Ratio is estimated to decrease to -1.29. Dianthus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of September 2023 | 200 Day MA 26.1883 | 50 Day MA 27.584 |
Dianthus |
Sharpe Ratio = -0.0663
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DNTH |
Estimated Market Risk
| 3.58 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Dianthus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dianthus Therapeutics by adding Dianthus Therapeutics to a well-diversified portfolio.
Price Book 2.0461 | Enterprise Value Ebitda (7.35) | Price Sales 128.8457 | Shares Float 13.6 M | Wall Street Target Price 51.8 |
Dianthus Therapeutics Valuation on December 31, 2023
It is possible to determine the worth of Dianthus Therapeutics on a given historical date. On December 31, 2023 Dianthus was worth 10.13 at the beginning of the trading date compared to the closed value of 10.4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Dianthus Therapeutics stock. Still, in general, we apply an absolute valuation method to find Dianthus Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Dianthus Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Dianthus Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 10.83 | 11.43 | 10.02 | 10.13 | 16,800 | |
12/29/2023 | 10.13 | 10.80 | 10.13 | 10.40 | 8,800 |
| 10.28 | 11.45 | 10.22 | 11.45 | 19,000 |
| Backtest Dianthus Therapeutics | | | Dianthus Therapeutics History | | | Dianthus Therapeutics Valuation | Previous | Next |
Dianthus Therapeutics Trading Date Momentum on December 31, 2023
| On January 02 2024 Dianthus Therapeutics was traded for 11.45 at the closing time. The top price for the day was 11.45 and the lowest listed price was 10.22 . The trading volume for the day was 19 K. The trading history from January 2, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 10.10% . The overall trading delta against the current closing price is 23.56% . |
Dianthus Therapeutics Fundamentals Correlations and Trends
By evaluating Dianthus Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Dianthus Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Dianthus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Dianthus Therapeutics Stock history
Dianthus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Dianthus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Dianthus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Dianthus Therapeutics stock prices may prove useful in developing a viable investing in Dianthus Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 5.2 M | 2.8 M | |
| Net Loss | -25.6 M | -26.9 M |
Dianthus Therapeutics Quarterly Net Working Capital |
|
Dianthus Therapeutics Stock Technical Analysis
Dianthus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Dianthus Therapeutics Period Price Range
Low | November 19, 2024
| High |
0.00 | 0.00 |
Dianthus Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Dianthus Therapeutics November 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Dianthus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dianthus Therapeutics shares will generate the highest return on investment. By undertsting and applying Dianthus Therapeutics stock market strength indicators, traders can identify Dianthus Therapeutics entry and exit signals to maximize returns
Dianthus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Dianthus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Dianthus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Dianthus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.67) | |||
| Treynor Ratio | (0.18) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Dianthus Stock analysis
When running Dianthus Therapeutics' price analysis, check to measure Dianthus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dianthus Therapeutics is operating at the current time. Most of Dianthus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dianthus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dianthus Therapeutics' price. Additionally, you may evaluate how the addition of Dianthus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |